300194 福安药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.7586.5535.7325.329-7.580
总资产报酬率 ROA (%)2.7844.6823.9123.532-5.084
投入资产回报率 ROIC (%)3.0455.2694.5374.109-5.975

边际利润分析
销售毛利率 (%)36.67652.95853.36558.36962.845
营业利润率 (%)12.85113.41611.2737.372-24.091
息税前利润/营业总收入 (%)12.64612.76410.8807.726-24.145
净利润/营业总收入 (%)12.61011.6328.8538.292-24.849

收益指标分析
经营活动净收益/利润总额(%)35.20485.59765.22865.775-26.780
价值变动净收益/利润总额(%)61.00214.17526.79532.830-8.864
营业外收支净额/利润总额(%)-0.691-2.771-2.8015.7180.167

偿债能力分析
流动比率 (X)2.1801.6841.7791.4971.618
速动比率 (X)1.4580.9901.1870.9381.128
资产负债率 (%)25.35726.43530.57632.86032.255
带息债务/全部投入资本 (%)16.53315.77217.71914.40518.781
股东权益/带息债务 (%)488.532515.280448.666546.979401.453
股东权益/负债合计 (%)294.239278.140226.838204.249202.874
利息保障倍数 (X)-108.040-43.986-126.154-83.0581,778.227

营运能力分析
应收账款周转天数 (天)36.09533.17938.52847.18644.339
存货周转天数 (天)248.295249.404208.099241.324241.343